InvestorsHub Logo
Followers 0
Posts 29
Boards Moderated 0
Alias Born 11/10/2008

Re: None

Wednesday, 06/20/2018 3:53:53 AM

Wednesday, June 20, 2018 3:53:53 AM

Post# of 4273
I think you're right, moving up even on small volume, it's about to pop, and OptiMist, buyout if it happens, will be way above 5 USD, it will pop to 5 before any offer is on the table, I really prefer they keep at it, the Company can be worth so much more.

Another thing, revenues are looking fine, so I don't understand why people are so aggressive towards management, USD 34.5 million for first 23 weeks, with the expected growth from https://sites.google.com/view/trustat/prescription-numbers
2018 revs will be USD 116 million. Even without growth they would hit USD 91 million on current sales.

Shorts are 31.57% of float, they can't keep it down anymore, they need to start covering. Days to cover is 23.5!!! They use the same strategy on all small biotechs, because it works on 90% of them, they end up bankrupt, this will not, the product will actually be a success.

This could be a 1000% in a year kind of stock.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.